| Fund ID | 805-9331794285 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | No |
| Prepared per GAAP | No |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 1% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Valiant Consano II, LLC | Private Equity | $15M |
| Valiant Bmc, LLC | Private Equity | $11M |
| Valiant Worldwide Stages, LLC | Private Equity | $10.5M |
Valiant Regenexx, LLC reports $8.5 million in gross assets, among the top 79% of private funds by size.
The stated minimum investment is $50,000.
Valiant Regenexx, LLC is managed by Valiant Wealth, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.